XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Series 1, Series 2 and Bridge warrant
Common Stock
Common stock - voting
Series 1, Series 2 and Bridge warrant
Additional paid-in capital
Series 1, Series 2 and Bridge warrant
Series 3 warrants
Common Stock
Common stock - voting
Series 3 warrants
Additional paid-in capital
Series 3 warrants
Series 1, Series 2, and 2019 Bridge Note warrants June 2020
Common Stock
Common stock - voting
Series 1, Series 2, and 2019 Bridge Note warrants June 2020
Additional paid-in capital
Series 1, Series 2, and 2019 Bridge Note warrants June 2020
ELOC
Additional paid-in capital
ELOC
Private Investment in Public Entities
Common Stock
Common stock - voting
Private Investment in Public Entities
Additional paid-in capital
Private Investment in Public Entities
At The Market Offering
Common Stock
Common stock - voting
At The Market Offering
Additional paid-in capital
At The Market Offering
Common Stock
Common stock - voting
Common Stock
Common stock - non-voting
Additional paid-in capital
Noncontrolling Interest
Accumulated deficit
Series D perpetual preferred stock
Total
Beginning Balance at Dec. 31, 2020                                   $ 4   $ 184,097   $ (166,899)   $ 17,202
Beginning Balance (in shares) at Dec. 31, 2020                                   38,007,420 2,120,786          
Increase (decrease) in Stockholders' Equity (Deficit)                                                
Issuance of common stock             $ 1 $ 23,233 $ 23,234       $ 975 $ 975   $ 5,365 $ 5,365              
Issuance of common stock (In shares)             4,028,290         416,664     669,850                  
Shares issued on conversion of Napo merger common shares (in shares)       602                                        
Shares issued to Iliad in exchange of notes payable and accrued interest                                       2,982       2,982
Shares issued to Iliad in exchange of notes payable and accrued interest (in shares)                                   588,235            
Issuance of warrants                   $ 124 $ 124                          
Shares issued in extinguishment of Exchange Note 2                                       2,516       2,516
Shares issued in extinguishment of Exchange Note 2 (in shares)                                   471,202            
Value of shares issued on exercise of warrants   $ 2,034 $ 2,034   $ 1,776 $ 1,776                                    
Shares issued on exercise of warrants 1,383,524     206,915                                        
Shares issued upon exercise of stock options                                       2       2
Shares issued upon exercise of stock options (in shares)                                   1,296            
Stock-based compensation                                       1,665       1,665
Net loss                                           (26,090)   (26,090)
Ending Balance at Jun. 30, 2021                                   $ 5   224,769   (192,989)   31,785
Ending Balance (in shares) at Jun. 30, 2021                                   45,773,998 2,120,786          
Ending Balance (in shares) at Dec. 31, 2021                                             0  
Beginning Balance at Dec. 31, 2020                                   $ 4   184,097   (166,899)   17,202
Beginning Balance (in shares) at Dec. 31, 2020                                   38,007,420 2,120,786          
Ending Balance at Dec. 31, 2021                                   $ 5   231,100 $ 242 (219,494)   11,853
Ending Balance (in shares) at Dec. 31, 2021                                   48,352,527 2,120,786          
Beginning Balance at Mar. 31, 2021                                   $ 4   210,795   (178,908)   31,891
Beginning Balance (in shares) at Mar. 31, 2021                                   42,635,466 2,120,786          
Increase (decrease) in Stockholders' Equity (Deficit)                                                
Issuance of common stock             $ 1 $ 9,835 $ 9,836                              
Issuance of common stock (In shares)             2,549,000                                  
Shares issued on conversion of Napo merger common shares (in shares)       1                                        
Shares issued to Iliad in exchange of notes payable and accrued interest                                       2,982       2,982
Shares issued to Iliad in exchange of notes payable and accrued interest (in shares)                                   588,235            
Issuance of warrants                   $ 124 $ 124                          
Shares issued upon exercise of stock options                                       2       2
Shares issued upon exercise of stock options (in shares)                                   1,296            
Stock-based compensation                                       1,031       1,031
Net loss                                           (14,081)   (14,081)
Ending Balance at Jun. 30, 2021                                   $ 5   224,769   (192,989)   31,785
Ending Balance (in shares) at Jun. 30, 2021                                   45,773,998 2,120,786          
Ending Balance (in shares) at Jun. 30, 2022                                             0  
Beginning Balance at Dec. 31, 2021                                   $ 5   231,100 242 (219,494)   11,853
Beginning Balance (in shares) at Dec. 31, 2021                                   48,352,527 2,120,786          
Increase (decrease) in Stockholders' Equity (Deficit)                                                
Issuance of common stock                             $ 3 11,561 11,564              
Issuance of common stock (In shares)                             26,814,743                  
Shares issued to Iliad in exchange of notes payable and accrued interest                                   $ 1   4,699       4,700
Shares issued to Iliad in exchange of notes payable and accrued interest (in shares)                                   9,793,643            
Share issued upon exercise of restricted stock units                                       95       95
Share issued upon exercise of restricted stock units (Shares)                                   174,196            
Shares issued to third party for services                                       19       19
Shares issued to third party for services (in shares)                                   35,000            
Stock-based compensation                                       2,080       2,080
Net loss                                         (201) (27,353)   (27,554)
Ending Balance at Jun. 30, 2022                                   $ 9   249,554 41 (246,847)   2,757
Ending Balance (in shares) at Jun. 30, 2022                                   85,170,109 2,120,786          
Ending Balance (in shares) at Jun. 30, 2022                                             0  
Beginning Balance at Mar. 31, 2022                                   $ 8   245,517 64 (237,480)   8,109
Beginning Balance (in shares) at Mar. 31, 2022                                   77,073,990 2,120,786          
Increase (decrease) in Stockholders' Equity (Deficit)                                                
Issuance of common stock                             $ 1 $ 2,453 $ 2,454              
Issuance of common stock (In shares)                             6,768,280                  
Shares issued to Iliad in exchange of notes payable and accrued interest                                       467       467
Shares issued to Iliad in exchange of notes payable and accrued interest (in shares)                                   1,143,643            
Share issued upon exercise of restricted stock units                                       95       95
Share issued upon exercise of restricted stock units (Shares)                                   174,196            
Shares issued to third party for services                                       5       5
Shares issued to third party for services (in shares)                                   10,000            
Stock-based compensation                                       1,017       1,017
Net loss                                         (23) (9,367)   (9,390)
Ending Balance at Jun. 30, 2022                                   $ 9   $ 249,554 $ 41 $ (246,847)   $ 2,757
Ending Balance (in shares) at Jun. 30, 2022                                   85,170,109 2,120,786